Literature DB >> 24829400

ELABELA: a novel hormone in cardiac development acting as a new endogenous ligand for the APJ receptor.

Feng Xie1, Deguan Lv1, Linxi Chen2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24829400     DOI： 10.1093/abbs/gmu032

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN： 1672-9145            Impact factor:   3.848


× No keyword cloud information.
  6 in total

Review 1.  Endoplasmic reticulum stress: a novel mechanism and therapeutic target for cardiovascular diseases.

Authors:  Mei-qing Liu; Zhe Chen; Lin-xi Chen
Journal:  Acta Pharmacol Sin       Date:  2016-02-01       Impact factor: 6.150

Review 2.  Effects of apelin on the cardiovascular system.

Authors:  Anna Folino; Pier Giorgio Montarolo; Michele Samaja; Raffaella Rastaldo
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

3.  Elabela levels in patients with type 2 diabetes: can it be a marker for diabetic nephropathy?

Authors:  Erhan Onalan; Yusuf Doğan; Ebru Onalan; Nevzat Gozel; Ilay Buran; Emir Donder
Journal:  Afr Health Sci       Date:  2020-06       Impact factor: 0.927

4.  Serum elabela and apelin levels during different stages of chronic kidney disease.

Authors:  Xuehong Lu; Shengmao Liu; Rumei Luan; Wenpeng Cui; Yu Chen; Yixian Zhang; Yue Lu; Hong Zhang; Lin Shi; Lining Miao; Feng Xu
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

5.  The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis In Vitro and Induces Vasodilatation Without Desensitisation In Vivo.

Authors:  Cai Read; Duuamene Nyimanu; Peiran Yang; Rhoda E Kuc; Thomas L Williams; Christopher M Fitzpatrick; Richard Foster; Robert C Glen; Janet J Maguire; Anthony P Davenport
Journal:  Front Pharmacol       Date:  2021-01-21       Impact factor: 5.810

Review 6.  International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand.

Authors:  Cai Read; Duuamene Nyimanu; Thomas L Williams; David J Huggins; Petra Sulentic; Robyn G C Macrae; Peiran Yang; Robert C Glen; Janet J Maguire; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.